Stock 5CV CUREVAC N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions CureVac N.V. Deutsche Boerse AG

Equities

5CV

NL0015436031

Market Closed - Deutsche Boerse AG
Other stock markets
 17:05:21 31/05/2024 BST 		5-day change 1st Jan Change
3.58 EUR +5.29% Intraday chart for CureVac N.V. +3.23% -6.77%
05-28 CureVac, GSK Begin Dosing in Phase 2 Study for Seasonal Influenza Vaccine Candidate MT
05-28 CureVac N.V. Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. CVAC Stock
  4. 5CV Stock
  5. Revisions CureVac N.V.